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Sewage effluent from an Indian hospital
harbors novel carbapenemases and
integron-borne antibiotic resistance genes
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Abstract
Background: Hospital wastewaters contain fecal material from a large number of individuals, of which many are
undergoing antibiotic therapy. It is, thus, plausible that hospital wastewaters could provide opportunities to find
novel carbapenemases and other resistance genes not yet described in clinical strains. Our aim was therefore to
investigate the microbiota and antibiotic resistome of hospital effluent collected from the city of Mumbai, India,
with a special focus on identifying novel carbapenemases.
Results: Shotgun metagenomics revealed a total of 112 different mobile antibiotic resistance gene types,
conferring resistance against almost all classes of antibiotics. Beta-lactamase genes, including encoding clinically
important carbapenemases, such as NDM, VIM, IMP, KPC, and OXA-48, were abundant. NDM (0.9% relative
abundance to 16S rRNA genes) was the most common carbapenemase gene, followed by OXA-58 (0.84% relative
abundance to 16S rRNA genes). Among the investigated mobile genetic elements, class 1 integrons (11% relative
abundance to 16S rRNA genes) were the most abundant. The genus Acinetobacter accounted for as many as 30%
of the total 16S rRNA reads, with A. baumannii accounting for an estimated 2.5%. High throughput sequencing of
amplified integron gene cassettes identified a novel functional variant of an IMP-type (proposed IMP-81)
carbapenemase gene (eight aa substitutions) along with recently described novel resistance genes like sul4 and
blaRSA1. Using a computational hidden Markov model, we detected 27 unique metallo-beta-lactamase (MBL) genes
in the shotgun data, of which nine were novel subclass B1 genes, one novel subclass B2, and 10 novel subclass B3
genes. Six of the seven novel MBL genes were functional when expressed in Escherichia coli.
Conclusion: By exploring hospital wastewater from India, our understanding of the diversity of carbapenemases
has been extended. The study also demonstrates that the microbiota of hospital wastewater can serve as a
reservoir of novel resistance genes, including previously uncharacterized carbapenemases with the potential to
spread further.
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Background
The rise in antibiotic resistance is a serious growing
problem for human health [1]. Environmental and com-
mensal microbiota serves as sources for antibiotic resist-
ance genes (ARGs) that emerge over time in pathogens
through horizontal gene transfer [2, 3]. Characterization
of the environmental resistome, thus, would provide an
understanding of novel resistance factors that might be
encountered in clinics in the future. This in turn would
help to better understand the development of resistance
in pathogens and to prepare surveillance and control
measures to reduce their dissemination.
Recently, hidden Markov model (HMM)-based
methods have been developed for detecting ARGs from
shotgun sequence data [4–7]. We have successfully
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applied HMM to identify novel quinolone resistance
genes [8, 9] as well as 59 novel families of the subclass
B1 metallo-beta-lactamases (MBLs) capable of degrading
carbapenems from a variety of environments [10]. HMM
accurately predicts the gene fragments belonging to
specific gene classes, based on evolutionarily conserved
domains [11]. This leads to accurate detection of both
known and previously undescribed resistance genes in
genomic and metagenomic sequence data. Functional
metagenomics is another strategy that has the ability to
identify novel ARGs without apparent similarities to
known ARGs as it is based on a functional selection of
DNA fragments expressed in a surrogate host like
Escherichia coli [12]. With such an approach, we have
identified novel ARGs, including one encoding a carba-
penem hydrolyzing beta-lactamase, from river sediments
contaminated with drug production waste [13]. Several
studies, using functional metagenomics, have reported
novel resistance genes from a variety of environments
like human gut, soil, and seawater [14–18].
Neither approach relies on the host-bacteria being cul-
tivable, but both largely lack the ability to differentiate
between mobilized and non-mobilized genes. The latter
is a critical aspect for assessing risk associated with
ARGs [19, 20]. To overcome this, we have recently used
a high-throughput sequencing method for studying
genes associated with integrons [21]. Class 1 integrons
are frequently carried by human pathogens and very
often harbor ARGs. The integrons are usually located on
mobile genetic elements like plasmids and transposons,
providing the ability to move across cells, strains, and
species [22–24]. Using an approach of amplifying partial
class 1 integrons, the fourth mobile sulfonamide resist-
ance gene (sul4) was discovered together with several
other novel resistance genes, including those encoding
class D beta-lactamases conferring reduced susceptibility
to carbapenems in E. coli [21].
Hospital sewage represents a collection of fecal matter
of a large number of individuals including patients
undergoing antibiotic treatment, together with other
bacteria of environmental origin. Antibiotic residues in
hospital wastewaters may reach levels that potentially
could be selective for resistant strains [25–27]. Several
studies have accordingly shown that hospital effluents
can provide a rich variety of known ARGs and resistant
enteric pathogens [28–32]. It is therefore plausible that a
more explorative analysis could lead to the discovery of
novel ARGs, either easily accessible to pathogens or
already circulating among pathogens undetected.
Antibiotic resistance is a growing problem in India,
partly due to high consumption of broad-spectrum anti-
biotics, including carbapenems [1]. Both clinical and
environmental resistance has been on the rise in India in
the last decade [33]. For example, the incidences of
carbapenem resistance in Klebsiella isolates and the rate
of methicillin-resistant Staphylococcus aureus (MRSA)
infections have gone up in the last few years [20]. Noso-
comial infections with carbapenemase-producing organ-
isms (CPOs) are quite common in India [34], and
studies have shown that hospital environments are a
common reservoir of CPOs [28, 29]. A recent Indian
study has shown that hospital effluent contributes to the
spread of carbapenemases in the external environment
[30]. For these reasons, it is possible that the Indian hos-
pital effluent could provide a particularly rich variety of
carbapenemases, including not yet characterized forms.
With this background, we aimed at identifying and
characterizing novel ARGs in wastewater from an Indian
hospital, particularly with regards to carbapenemases.
This was achieved using two approaches—(1) investigat-
ing the antibiotic resistome and microbiota of sewage
effluent collected from a large hospital in the city of
Mumbai in India using Illumina HiSeq-based shotgun
metagenomics and identification of novel molecular
class B carbapenemases from the shotgun data using
hidden Markov models, and (2) investigating novel
mobile resistance genes by targeted amplicon sequencing
of integron gene cassettes using a combination of short-
read (Illumina MiSeq) and long-read (PacBio) sequen-
cing technologies followed by homology searches to
known ARGs. With these approaches, we detected
several recently discovered resistance genes as well as
genes encoding previously uncharacterized carbapene-
mases which we also functionally verified in E. coli.
Results
Shotgun sequencing of the hospital effluent metagenome
resulted in 1.72 × 108 filtered reads. A total of 193,098
reads (0.11% of the total reads) matched to ARGs.
Together, these accounted for 0.844 copies of ARGs per
16S rRNA gene. One hundred and twelve different
mobile ARG types conferring resistance against almost
all major classes of antibiotics were detected (Additional
file 1: Table S1).
Carbapenemases, class 1 integrase, and virulence genes
were common in hospital effluent
The sulfonamide resistance gene sul1 (11.4% relative
abundance to 16S rRNA genes) was the most abundant
resistance gene followed by the macrolide resistance
gene mphE (11.3% relative abundance to 16S rRNA
genes). Beta-lactamases were the most abundant gene
class detected followed by aminoglycoside and tetracyc-
line resistance genes (Additional file 1: Table S1).
Twenty-seven different beta-lactamase genes (Fig. 1,
Additional file 1: Table S1) were detected in the
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metagenome followed by 19 different genes conferring
resistance against aminoglycosides and tetracyclines.
OXA-10 and GES-type ESBLs were the dominant beta-
lactamases detected in the study. The detected beta-
lactamase genes also included those encoding clinically
important carbapenemases, such as NDM, VIM, IMP,
KPC, and OXA-48. Among the carbapenemases, NDM
had the highest abundance (0.9% relative abundance to
16S rRNA genes), which corresponds to approximately 1
in 25 bacterial cells carrying NDM, if we assume on an
average of 4 copies of the 16S rRNA gene per genome in
the microbial community [35, 36]. OXA-58 (0.84% rela-
tive abundance to 16S rRNA genes) was the second
most abundant carbapenemase, while OXA-48 and
OXA-24 had the lowest abundance (0.005% and 0.0025%
relative abundance to 16S rRNA genes, respectively).
Among the studied mobile genetic elements, class 1
integrase (10.9% relative abundance to 16S rRNA
genes) was the most common gene followed by ISCR2
and ISCR5 (Additional file 1: Table S1). Virulence
genes involved in pilus formation, capsule formation,
proteases, siderophore production, adhesion factors,
and toxins like cytolysin and hemolysin were also de-
tected (Additional file 2: Table S2). Some virulence
genes specific to certain pathogens including entero-
pathogenic E. coli (protease stcE, intimin), Salmonella
typhi (Vi antigen synthesis genes tviBC), Staphylococ-
cus aureus (clumping factor A clfA), Streptococcus
pneumoniae (fibronectin-binding protein fbp54), and
several virulence genes for Pseudomonas aeruginosa
were detected [37–40], indicating the presence of
these pathogens in the effluent sample.
Acinetobacter baumannii was abundant in hospital
effluent
At the phylum level, Proteobacteria dominated (75% of all
16S rRNA gene reads) followed by Bacteroidetes (16%)
and Firmicutes (1.75%). Within Proteobacteria, Gamma-
proteobacteria were the most abundant, followed by Beta-
proteobacteria. At genus level, Acinetobacter was found to
be the most dominant genera representing 30% of the 16S
rRNA reads (Additional file 3: Table S3). The abundance
of the OXA-51 gene, which is a characteristic for A.
baumannii [41], was 0.4% in relation to the total number
of 16S rRNA reads. Acinetobacter contains 6 copies of 16S
rRNA gene per genome [42]. This suggests that around
8% of total Acinetobacter (2.4% of the all 16S reads)
detected in the samples belong to A. baumannii, thus,
potentially representing pathogenic Acinetobacter strains.
Further, the presence of A. baumannii was confirmed by
alignment of the OXA-51 gene containing contigs from
the assembled shotgun sequence data to A. baumannii
genome that resulted in a perfect match. The reference-
based assembly using A. baumannii genome sequences
contained 1704 contigs (min 1 kilobases) with a total of
4.9 megabases. A single 9203 base pair long contig with
28-fold coverage matched to the original OXA-51 subse-
quence and was then used to identify the single closest
known full genome of A. baumannii strain AB6200
(accession NZ_CP010397.1, 99% nucleotide identity). An
alignment of the assembled contigs against this genome
sequence using D-Genies (http://dgenies.toulouse.inra.fr/)
[43] showed an extensive coverage of the genome by
assembled contigs with high matching identity (Additional
file 9: Figure S1).
Fig. 1 Relative abundance of different beta-lactamase genes detected in hospital effluent
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Carbapenemases and novel resistance genes, including a
novel IMP variant, were detected in integron gene
cassettes
Sequencing of gene cassette amplicons resulted in 106,
851 long PacBio reads with an average length of 1.5 kilo-
bases and 14,184,598 short Illumina reads (SRs) with a
maximum length of 250 bases. A total of 250,720 open
reading frames (ORFs) were identified. Clustering of all
identified ORFs at 99% amino acid identity led to 6098
unique ORFs. The list of genes detected in class 1 inte-
gron gene cassettes can be found in Additional file 4:
Table S4, and the list of known and putative novel ARGs
detected in class 1 integron gene cassettes can be found
in Additional file 5: Table S5. Several carbapenemases
including DIM-1, IMP-1, IMP-15, IMP-6, VIM-2, and
GES-type beta-lactamases were detected, along with
several putative novel resistance genes/gene variants
(Table 1). We also detected many variants of GES (GES-
2, GES-4, GES-5, GES-6, GES-14) capable of carba-
penem hydrolysis in gene cassettes from hospital efflu-
ent. Recently reported ARGs like blaRSA1 and sul4 were
also found as part of the gene cassettes. Interestingly, we
detected a novel variant of an IMP-type carbapenemase.
This novel variant (proposed-IMP-81) has 8 aa substitu-
tions compared to the closest known variant of IMP-15
(Fig. 2). This gene provided reduced susceptibility
against carbapenems when expressed in E. coli
(Additional file 6: Table S6) and was positive for imipe-
nem degradation in the CarbaNP test.
Novel class B carbapenemase genes outnumbered
previously characterized carbapenemases in the hospital
effluent microbiota
We applied a recently developed computational method
based on hidden Markov models to predict novel
subclass B1, B2, and B3 carbapenemases directly from
the shotgun data. In total, we detected 14 unique ORFs
representing subclass B1, one unique ORFs representing
B2, and 12 unique ORFs representing subclass B3,
respectively (Table 2). The phylogenetic trees for the
subclass B1/B2 and subclass B3 genes detected are pre-
sented as Additional file 10: Figure S2 and Additional
file 11: Figure S3. Out of the 27 unique ORFs, seven rep-
resented previously characterized genes, viz NDM-1,
Table 1 Putative novel resistance genes and gene variants detected in integron gene cassettes
Gene name Length
(amino acid)






aadA- like-1 288 Aminoglycoside adenyltransferase, partial [Escherichia coli] 89 AEG64741.1 Aminoglycosides
sat-like-1 301 Streptomycin 3-adenylyltransferase [Yersinia pestis biovar
Orientalis str. IP275]
94 EDR32758.1 Aminoglycosides
aadA- like-2 287 Aminoglycoside adenyltransferase, partial (plasmid) [Escherichia coli] 94 AIL81899.1 Aminoglycosides
CAT-like 170 Chlor_Acetyltrans_CAT, partial [uncultured bacterium] 92 AMP56890.1 Amphenicols
blaRSA1* 270 Class A extended-spectrum beta-lactamase BEL-1
[Pseudomonas aeruginosa]
53 WP_063857830.1 Beta-lactams
OXA-like-1 300 Class D [uncultured bacterium] 87 AMP47162.1 Beta-lactams
OXA-like-2 266 Class D [uncultured bacterium] 91 AMP48561.1 Beta-lactams
OXA-like-3 266 Oxacillin-hydrolyzing class D beta-lactamase OXA-10
[Gammaproteobacteria]
92 WP_000846390.1 Beta-lactams





329 Beta-lactamase [Vibrio cholerae non-O1/non-O139] 94 BAE71359.1 Beta-lactams
OXA-like-5 275 Oxacillin-hydrolyzing class D beta-lactamase OXA-2 [Proteobacteria] 95 WP_001007673.1 Beta-lactams
IMP-like-1
(IMP-81)
246 Subclass B1 metallo-beta-lactamase IMP-15 [Pseudomonas aeruginosa] 96 WP_063860575.1 Beta-lactams
qacE-like-1 110 QacE [uncultured bacterium] 81 ACN22612.1 Disinfectants
qacG-like-1 96 QacG, partial [uncultured bacterium] 90 ACS73614.1 Disinfectants
arr-like-1 150 NAD(+)--rifampin ADP-ribosyltransferase Arr-6
[Pseudomonas aeruginosa]
86 WP_063842214.1 Rifampicin
sul4# 280 Dihydropteroate synthase [Ardenticatena] 68 CUS02277.2 Sulfonamides
Dfr-like 1 107 Dihydrofolate reductase [Pseudomonas aeruginosa] 88 BAT62904.1 Trimethoprim
Dfr-like 2 157 Dihydrofolate reductase, partial [Vibrio cholerae] 89 AAT37842.1 Trimethoprim
*The sequence is 100% identical to blaRSA1
#The sequence is 100% identical to sul4
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IMP-1, IMP-15, VIM-2, DIM-1, POM-1, and L1, respect-
ively. We detected nine putative novel subclass B1, one
novel subclass B2, and 10 novel subclass B3 carbapene-
mases, respectively. The list of these genes and the clos-
est blast hits are presented in Table 2. The putative
novel subclass B2 gene (2N30) was expressed in E. coli,
and the CarbaNP test confirmed its ability to hydrolyze
imipenem. Seven of the novel predicted B3 carbapene-
mases were synthesized and tested for imipenem degrad-
ation using CarbaNP test. Six out of the seven genes
were positive for the test (Table 2). One of the subclass
B1(1N7) protein falls in the same phylogenetic cluster as
SPS-1 (Additional file 10: Figure S2). This enzyme has a
substitution at position 116 (histidine at position 116 is
replaced by a glycine), consistent with other enzymes
belonging to this phylogenetic cluster [10].
Discussion
In order to identify novel resistant determinants, par-
ticularly carbapenemases, we explored sewage effluent
collected from a hospital in India, a country with high
use of carbapenems and widespread problems with car-
bapenemase resistance. Using both hidden Markov
models on shotgun data, as well as amplicon sequencing
of integron gene cassettes, we found several novel ARGs.
These include several different carbapenemases that also
turned out to be functional when expressed in E. coli.
The present study therefore expands our knowledge of
novel resistance genes. The co-occurrence of pathogens
and novel resistance genes to critically important
antibiotics offers increased opportunities for unwanted
horizontal gene transfer events. Hence, the studied hos-
pital sewage environment appears to provide an example
of the “ecological connectivity” [20] needed for genes to
move across niches and environments to eventually
become clinical problems.
We demonstrate the presence of a functional novel
variant of a mobile IMP-type (proposed IMP-81) carba-
penemase as a gene cassette within a class 1 integron.
IMP-1 was the first mobile MBL detected and is one of
the five major clinical carbapenemases found globally
[44, 45]. Identification of this novel variant could reflect
that MBLs are constantly evolving. Indeed, its presence
in sewage from an Indian hospital could potentially be
linked to its evolution as a result of high consumption
of broad-spectrum antibiotics, including carbapenems,
in India [1, 46]. Using shotgun metagenomics and com-
putational models, we have substantially increased our
understanding about the diversity of MBLs. Although
several studies have detected known MBLs in hospital
effluent, to the best of our knowledge, none of the stud-
ies have detected as many novel MBLs in hospital efflu-
ent to date [28, 30, 47]. We extended our previous
subclass B1 model for the detection of subclass B3
Fig. 2 a Sequence alignment of novel IMP variant (proposed IMP-81) detected in our study with IMP variants 1, 5, and 15, respectively. Black
color indicates consensus. Multiple sequence alignment obtained using BoxShade https://embnet.vital-it.ch/software/BOX_form.html. b
Phylogenetic tree for IMP variants
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MBLs and found 2 known and 10 putative novel B3
carbapenemases. Six out of seven predicted and synthe-
sized B3 genes were functional in E. coli, thus demon-
strating the high accuracy of our approach. Four of the
predicted B3 genes belong to the same part of the phylo-
genetic tree as the clinically important L1 beta-
lactamase and the only known version of B3 carbapene-
mases located on a plasmid, AIM-1 [48, 49]. Although
these genes are functional in E. coli, the computational
prediction does not provide information about their
genetic context. Hence, we do not know their potential
for mobility nor the host species for these genes. Further
investigation of genetic context and host species identifi-
cation is thus warranted.
NDM was the most abundant of the clinical carbape-
nemase detected in the effluent. This finding is in
accordance with the clinical data on carbapenemase pro-
ducing pathogens from Mumbai [50]. A recent study
showed that NDM-1 is also common in hospital efflu-
ents from Delhi, India [30]. Interestingly, we detected
OXA-58 as the second most abundant carbapenemase
gene. OXA-58 has been found on a plasmid in Entero-
bacteriaceae, and it is a mobile carbapenemase regularly
encountered in Acinetobacter [51, 52]. A previous study
of ours showed that the abundance of OXA-58 in Indian
river sediments contaminated with untreated urban
waste strongly correlates with the abundance of Acineto-
bacter [53]. Similarly, the high abundance of OXA-58 in
the hospital effluent detected here can be explained by a
high abundance of Acinetobacter. The rates of A.
baumannii nosocomial infections have risen globally in
past decades [54]. Acinetobacter is invariably resistant to
Table 2 The list of MBLs detected using computational model and shotgun sequence data
Gene name MBL subclass Length aa Closest homolog in NCBI protein database % identity aa Accession number
DIM B1 202 Subclass B1 metallo-beta-lactamase DIM-1 [Pseudomonas stutzeri] 100.0 WP_063860203.1
NDM B1 248 Metallobetalactamase NDM-1 [Klebsiella pneumoniae] 100.0 AGC54622.1
IMP B1 240 Beta-lactamase IMP-1 precursor [Pseudomonas aeruginosa] 100.0 CRX26419.1
VIM B1 248 Subclass B1 metallo-beta-lactamase VIM-2 [Pseudomonadales] 100.0 WP_003108247.1
IMP B1 240 Subclass B1 metallo-beta-lactamase IMP-15 [Pseudomonas aeruginosa] 100.0 WP_063860575.1
1N26 B1 241 Beta-lactamase [uncultured bacterium] 74.79 ALG03680.1
1N27 B1 242 Subclass B1 metallo-beta-lactamase [bacterium 336/3] 71.97 WP_054042800.1
2N30* B2 252 ChpA family subclass B2 metallo-beta-lactamase [Aeromonas lacus] 51.48 WP_033113784.1
1N32 B1 241 Hypothetical protein A3D31_07435 [Fluviicola sp.
RIFCSPHIGHO2_02_FULL_43_260]
55.04 OGS79779.1
1N4 B1 247 Subclass B1 metallo-beta-lactamase [bacterium 336/3] 73.55 WP_054042800.1
1N59 B1 244 Hypothetical protein A2041_05420 [Bacteroidetes bacterium GWA2_31_9b] 52.7 OFX20903.1
1N6 B1 246 Subclass B1 metallo-beta-lactamase [bacterium 336/3] 59.5 WP_054042800.1
1N8 B1 234 Subclass B1 metallo-beta-lactamase [Flectobacillus major] 70.67 WP_044171073.1
1N9 B1 240 Beta-lactamase [uncultured bacterium] 66.53 ALG03680.1
1N7 B1 273 Hypothetical protein Gferi_08260 [Geosporobacter ferrireducens] 48.0 AOT69571.1
POM-1 B3 223 B3 beta-lactamase [Pseudomonas otitidis] 100.0 ADC79563.1
L-1 B3 210 LW82289.1 metallo-beta-lactamase L1 family protein
[Acinetobacter sp. WC-743]
99.52 WP_009585815.1
3N14 B3 283 Subclass B3 metallo-beta-lactamase [Phenylobacterium sp. Root700] 69.58 WP_056733210.1
3N32* B3 281 BJP_beta_lactamase [uncultured bacterium] 61.59 AIA10847.1
3N33 B3 289 BJP_beta_lactamase [uncultured bacterium] 61.4 AIA10847.1
3N40* B3 290 Subclass B3 metallo-beta-lactamase [Phenylobacterium sp. Root700] 69.96 WP_056733210.1
3N51* B3 299 Subclass B3 metallo-beta-lactamase [Novosphingobium sp. PP1Y]C 70.57 WP_013834039.1
3N55* B3 284 Subclass B3 metallo-beta-lactamase [Phenylobacterium sp. Root700]K 70.82 WP_056733210.1
3N61* B3 297 Subclass B3 metallo-beta-lactamase [Croceicoccus marinus] 57.65 WP_066847047.1
3N73# B3 295 BJP_beta_lactamase [uncultured bacterium] 62.98 AIA10847.1
3N8 B3 297 Subclass B3 metallo-beta-lactamase [Sphingomonadaceae]E 55.85 WP_008831296.1
3N1* B3 300 Subclass B3 metallo-beta-lactamase [Novosphingobium sp. Leaf2] 53.0 WP_056771586.1
*These genes were positive in the CarbaNP test
#This gene was negative in the CarbaNP test
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multiple antibiotics, including last resort drugs like carba-
penems and colistin, making treatment difficult. Acineto-
bacter often carries conjugative plasmids bearing multidrug
resistance markers and carbapenemases belonging to the
OXA-type as well as MBLs. Acinetobacter can readily ex-
change these plasmids carrying drug resistance markers
with members of family Enterobacteriaceae [51, 55].
GES-type beta-lactamases were the second most abun-
dant ESBLs in our study, with several variants capable of
low-level hydrolysis of carbapenems [56]. GES-carrying
carbapenem-resistant strains have been previously iso-
lated from hospital effluent [57]. GES-type ESBL genes
are found globally and exclusively as integron gene cas-
settes in Gram-negative pathogens, including P. aerugi-
nosa, E. coli, K. pneumoniae, and A. baumannii [58].
The high abundance of GES-type beta-lactamases in the
shotgun dataset can at least partly be explained by high
abundance of class 1 integrons in our samples. The
recently discovered ESBL gene blaRSA1 was also detected
in integron gene cassettes here. The blaRSA1 gene is
phylogenetically close to GES-type ESBLs. The beta-
lactam hydrolytic profile of the blaRSA1 protein resem-
bled that of GES-2. Although blaRSA1 does not hydrolyze
carbapenems, there is a possibility that natural mutants
might occur which may possess this activity, as is the
case for other GES variants [13]. The same may apply
for other ESBLs, as was recently demonstrated by the
discovery of a natural mutant of OXA-10 with increased
carbapenemase activity in Swedish hospital effluent [59].
Sulfonamide resistance genes are common in domestic
and hospital effluents [60]. Our results showed that sul1
was the most abundant mobile resistance gene, which is
in accordance with a previous study of hospital wastewa-
ter [60]. The recently described novel sulfonamide resist-
ance gene sul4 was detected along with the ISCR20
transposes as described earlier [21]. Both sul4 and
blaRSA1 were first described from river sediments con-
taminated with waste from drug manufacturing plants
near Hyderabad, India, and concerns were raised about
finding these genes in clinical isolates [13, 21]. The pres-
ence of these genes in integron gene cassettes from hos-
pital effluent suggests that these genes are accessible to
pathogens and might already have made their way into
human pathogens. This finding also emphasizes the need
to explore and characterize environmental ARGs, which
may end up in clinics in the future.
Conclusions
We show that explorative studies for novel antibiotic
resistance determinant in hospital effluent can contrib-
ute to early identification of what may become future
clinical problems. An expanded knowledge of these
novel genes can facilitate actions to mitigate their poten-
tial spread in the clinic. Bacteria carrying novel ARGs,
including novel carbapenemases, co-exist with patho-
gens, thus creating a niche where the acquisition of
novel ARGs by pathogens may take place. It is also pos-
sible that such gene exchange is further boosted by the
expected presence of antibiotic residues [61, 62]. If
released untreated or inadequately treated, as in many
low- and middle-income countries, there is increased
opportunities for transmission of enteric pathogens,
including resistant ones [30]. Hence, hospital effluent
discharges also deserve attention from antimicrobial re-
sistance risk management point of view.
Methods
Sampling, DNA extraction, and shotgun sequencing
Effluent samples were collected directly from the sewer
line from a hospital in Mumbai, India, on 2 different
days (30 October 2014 and 1 November 2014). Each
sample comprised composite sample collected every
hour (100 ml each time) during the day from 8 a.m. to 6
p.m. in a sterile plastic bottle. The sub-samples were
stored at a temperature of 4 °C, mixed together and fil-
tered on the same day using a 0.2-μM filter. DNA was
extracted from the filters using QIAamp DNA Stool
Mini Kit (Qiagen, Germany). The DNA was quantified
using dsDNA High Sensitivity (HS) Assay kit on the
Qubit® Fluorometer (Invitrogen, USA) and stored at −
20 °C. The DNA was sent for shotgun metagenomic
sequencing (paired-end, 125 base pair reads) on Illumina
HiSeq2500 platform at Science for Life Laboratories
(Stockholm, Sweden).
Sequence analysis of shotgun metagenomic data
The sequence analysis was performed according to the
protocol described by Marathe et al. [53]. In brief, the se-
quences were trimmed for adaptors and quality-filtered
using Trim Galore (http://www.bioinformatics.babraham.
ac.uk/projects/trim_galore/) with a phred quality score of
28 and a maximum error rate (the number of errors
divided by the length of the matching region) of 0.1. The
quality-processed reads from the metagenomes were
mapped against protein sequences from a high-quality
and manually curated database of mobile ARGs and mo-
bile genetic elements, Resqu database (Resqu database;
version 1.1; 1928 Diagnostics, Gothenburg; http://www.
1928diagnostics.com/resdb), which contains ARGs that
have been previously reported to be horizontally trans-
ferred or carried on a mobile genetic element. Full-length
coverage of the query reads was set against target resist-
ance genes with a sequence identity threshold of 90%, and
only the best hits were retrieved (options “-usearch_global
-id 0.9 maxaccepts 1 -threads 16”). The list of resistance
genes in the Resqu database is given in Additional file 7:
Table S7. Analysis of bacterial virulence-associated genes
(virulence factors) in the metagenomes was performed
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using a set of experimentally verified virulence factors
collected from the Virulence Factor Database (http://
www.mgc.ac.cn/VFs/) [63]. To characterize the overall
taxonomic distribution, quality-filtered shotgun reads
were used as input to extract the reads corresponding to
small subunit (SSU) 16S bacterial ribosomal RNA genes
from the metagenomes and assigned them to different
taxonomic groups using Metaxa2 (version 2.1) with de-
fault options [64].
PCR amplification and sequencing of integron gene
cassettes
Amplification of integron gene cassettes was performed
according to the protocol described by Razavi et al. [21].
In brief, integron gene cassettes were amplified from the
hospital effluent DNA using three sets of primers previ-
ously described using phusion taq polymerase (thermo-
scientific, USA). PCR products were purified using
QIAquick PCR Purification Kit (Qiagen, Germany) and
quantified using the Qubit® Fluorometer (Invitrogen,
USA). The purified PCR products were sent for single-
molecule real-time (SMRT) sequencing technology
(Pacific Biosciences) and shotgun metagenomic sequen-
cing to produce (paired-end 250 base pair reads on the
Illumina MiSeq platform) at Science for Life Laborator-
ies in Uppsala and Stockholm, respectively.
Sequence analysis of integron gene cassettes
Sequence analysis was performed using the method de-
scribed by Razavi et al., 2017. In brief, quality-filtered
PacBio reads were corrected using Illumina reads with a
hybrid correction pipeline for SMRT sequencing, i.e.,
Proovread [65]. Reads were clustered at 100% identity
using CD-HIT to remove redundancy. The open reading
frames (ORFs) were predicted using Prodigal [66] and
annotated through similarity searches against the NCBI
non-redundant protein (nr) databases (13 April 2017).
Putative novel resistance genes were identified based on
their sequence identity and the length of the alignment
(coverage) to known homologs genes both in the CARD
(version 1.1.0, REF) and the NCBI nr protein databases.
Integron gene cassettes are expected to carry a wide
array of genes, including ARGs. Hence CARD and NCBI
(nr), which are broader databases compared to Resqu,
were used for characterizing integron gene cassettes. We
classified ORFs with at least 95% identity to closest
homologs in the CARD database as “known resistance
genes.” Although the exact cutoff is subjective, this has
been used by others in the past [67]. We classified ORFs
with a best match to a resistance gene in the CARD
database as “putative novel resistance genes” if they had
an identity below 95% and a coverage greater than 65%
[21]. The gene cassettes with known functions were
clustered at 99% identity cutoff to remove redundancy
using CD-HIT. HattCI was used to identify the attach-
ment site attC in the reads [68].
Prediction of class B beta-lactamases
The novel MBL genes were identified from shotgun
sequence data using a computational method based on a
hidden Markov model (HMM) reported recently [5, 10].
For identification of subclasses B1 and B2, the model
was built using HMMER (version 3.1b1) and trained
using 20 verified genes in the B1 MBLs subclass, while
the model for subclass B3 was trained using 11 verified
genes belonging to subclass B3. The list of the genes is
represented in Additional file 8: Table S8. The subclasses
B1 and B2 are rather similar while B3 is distinctly differ-
ent, based on sequence identity. Also, phylogenetic
evidence suggests that the resistance mechanisms of the
subclasses B1, B2, and B3 may have developed independ-
ently [69, 70]. Hence, one model can detect both B1 and
B2 genes, while a different model was created for B3
genes. The created and optimized models were applied
directly to the fragmented data (short reads) and the
fragments predicted to belong to either subclass B1, B2,
or B3 were retrieved and assembled into full-length
genes using SPAdes version 3.8.1 with parameter
“—meta” [71]. The full-length genes were then once
again subjected to the hidden Markov models, this time
using a threshold score optimized for full-length genes.
The genes that passed the final classification step were
retrieved and clustered at a 70% amino acid sequence
similarity together with previously characterized MBLs
using USEARCH with parameters “-cluster_fast -id 0.7”
[72]. The list of previously characterized MBLs used in
clustering can be seen in Additional file 8: Table S8.
Functional verification of candidate novel resistance
genes
For each antibiotic class (except aminoglycosides, as the
expression vector contained a kanamycin resistance
gene), we selected one putative novel resistance gene/
gene variant detected in integron gene cassettes for
functional verification. Among the genes that had their
best match to a known resistance gene, we chose the
one with the lowest identity to a known ARG for each
antibiotic class. Genes with > 95% identity to a resistance
gene in CARD were not tested, with the exception of a
putative novel IMP gene that had 96% identity to a
known ARG. The reason for this is that carbapenemase
genes are clinically very important and even small
changes in MBL protein sequence may change their
hydrolytic profile [73]. With regards to novel MBLs
derived from the HMM analyses, seven novel genes from
different clades of phylogenetic tree representing sub-
class B3 were selected for functional verification along
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with one gene representing subclass B2. The candidate
novel genes were synthesized at ThermoFisher Scientific,
Germany, using their GeneArt Gene Synthesis service
and subcloned into the expression vector pZE21-MCS1
as described previously [13]. The plasmids containing
novel resistance gene candidates were then transformed
into E. coli C600Z1 (Expressys, Germany) by electropor-
ation. The minimum inhibitory concentrations (MICs) of
the respective antibiotics for the E. coli strains containing
synthesized candidate novel resistance genes were deter-
mined using E-tests on Mueller-Hinton Agar plates
(BioMérieux, France) with the addition of 100 ng/μl anhy-
drotetracycline as an inducer of the expression. E. coli
strain containing an empty vector was used as a negative
control. For verification of a putative novel IMP variant
and MBLs, CarbaNP test was carried out as described
earlier [74]. CarbaNP test is a biochemical test based on
the detection of the acidification resulting from imipenem
hydrolysis by carbapenemases [74].
De novo assembly of Acinetobacter baumannii reads
Illumina reads that aligned with at least 90% identity to
the nucleotide sequence of the type OXA-51 gene from A.
baumannii strain AB030 (accession NZ_CP009257.1)
were identified using BBMap (v38.32, “maxindel=2
minid=0.90 idfilter=0.90 strictmaxindel”) and were then
assembled using MEGAHIT (v1.1.3, defaults) [75, 76].
The resulting 1341 base pair contig with a 26-fold cover-
age was searched against NCBI database using Entrez (18
Jan. 2019), and the genomes which contained highly simi-
lar homologs were selected (accessions NZ_KB849297.1,
NZ_KB849308.1, NZ_CP033754.1, NZ_CP022283.1, NZ_
CP027530.1, NZ_CP018332.1, NZ_CP020597.1, NZ_
LN997846.1, NZ_LN865143.1). These were again used to
recruit read pairs using BBMap (previous parameters) and
then assembled using MEGAHIT (previous parameters).
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